Laboratory efficacy of Bactivec ® and Griselesf ® biolarvicides used for large-scale larviciding in Tanzania
dc.contributor.author | Tegemeo, Gavana | |
dc.contributor.author | Kailembo, Denis | |
dc.contributor.author | Machange, Jane | |
dc.contributor.author | Venance Michael | |
dc.contributor.author | Swai, Kyeba | |
dc.contributor.author | Olukayode, Odufuwa | |
dc.contributor.author | Tenywa, Frank | |
dc.contributor.author | Mwalimu, Charles | |
dc.contributor.author | Jubilate Bernard | |
dc.contributor.author | Samwel Lazaro | |
dc.contributor.author | Best Yoram | |
dc.contributor.author | Kajange, Stella | |
dc.contributor.author | Kasagama, Elizabeth | |
dc.contributor.author | Kisoka, Noela | |
dc.contributor.author | Mbuba, Emmanuel | |
dc.contributor.author | Chaki, Prosper | |
dc.contributor.author | Lengeler, Christian | |
dc.contributor.author | Moore, Sarah | |
dc.date.accessioned | 2025-09-20T07:05:28Z | |
dc.date.issued | 2025-07-21 | |
dc.description | SDG - 3: Good Health and Well-being SDG - 9: Industry, Innovation and Infrastructure SDG -13: Climate Action SDG -17: Partnerships for the Goals | |
dc.description.abstract | From 2022 to 2024, a project piloting large-scale larviciding in Tanzania was implemented in Tanga Region. The project used in-country manufactured biolarvicides, The study was conducted at Ifakara Health Institute (IHI) in Tanzania. Laboratory-based dose–response experiments were performed using Bactivec® and Griselesf® against laboratory-reared early third instar larvae of Anopheles gambiae sensu stricto, Anopheles arabiensis, Anopheles funestus, Aedes aegypti and Culex quinquefasciatus. Larvae were exposed to various concentrations of Bactivec® and Griselesf®. VectoBac® served as a positive control, and distilled water as a negative control. Twelve replicates per concentration, with 25 larvae per replicate, were tested. Larval mortality was recorded at 24 and 48 hours after exposure to Bactivec® and Griselesf®, respectively. Probit regression analysis was used to determine the lethal concentration (LC50 and LC90) values.Bactivec® and Griselesf®. This study independently assessed the efficacy of both biolarvicide products to ensure that they represented a good option for scaling up. | |
dc.identifier.uri | https://doi.org/10.3389/fmala.2025.1614476 | |
dc.identifier.uri | https://dspace.nm-aist.ac.tz/handle/123456789/3262 | |
dc.language.iso | en | |
dc.publisher | Frontiers | |
dc.title | Laboratory efficacy of Bactivec ® and Griselesf ® biolarvicides used for large-scale larviciding in Tanzania | |
dc.type | Book |